The department of Pathology supports a robust research program including over 100 research faculty in over 40 laboratories, with 12 endowed professorships. Broad areas of research interests encompass basic, translational and clinical sciences, and utilize state of the art multi-disciplinary approaches investigating the pathobiology of human disease. Research programs in U-M Pathology encompass a wide range of topics in the areas of Aging, Allergy, Cancer Biology, Development & DNA repair, Inflammation and Immunology, Mucosal Inflammation and Epithelial Pathobiology, Neurobiology/Pathology and Bioinformatics. Research strengths are further complemented by innovative clinical and translational research programs in Anatomic and Clinical Pathology.
Pathology research at U-M is supported by funding from the NIH, NSF, DOD, private foundations and pharmaceutical industry and ranks in the top ten nationally among Pathology Departments. Our recruitment efforts as well as recent funding successes have positioned U-M Pathology as a leading research destination in Pathology nationally.
The Department of Pathology and the American Society for Investigative Pathology (ASIP) are proud to host the interactive, abstract-driven 2018 Pathobiology for Investigators, Students and Academicians Conference (PISA), in Ann Arbor, Michigan. This year’s event, Molecular Mechanisms of Disease: Tissue Homeostasis, Immune Responses and Cancer.
Dr. Gabriel Nuñez, the Paul de Kruif Endowed Professor of Pathology, is one of the newest members of the National Academy of Medicine. The Nuñez laboratory has made ground-breaking discoveries in the field of [...]
Congratulations to Steven L. Kunkel, PhD, on his appointment as the executive vice dean for research and chief scientific officer of the University of Michigan Medical School, effective September 1, 2019, following a nationwide search for the best candidate. Kunkel previously served [...]
Surinder Kumar, Ph.D., has received The Pablove Foundation Childhood Cancer Research Grant for his proposal entitled “The sirtuin SIRT5 as a novel therapeutic target for Ewing’s Sarcoma” [...]